Osimertinib Benefit in ctDNA T790M Positive, EGFR-Mutant NSCLC Patients

Authors:

J Remon, C Caramella, C Joelet, L Lacroix, A Lawson, S Smalley, K Howarth, D Gale, N Rosenfeld, E Green, V Plagnol, D Planchard, M Bluthgen, A Gazzah, C Pannet, C Nicotra, J-C Soria, B Besse

Journal:

JOURNAL OF THORACIC ONCOLOGY

Citation info:

12(1):S1254-S1255

Publication date:

1st Aug 2017

Full text

DOI